Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C2H5NO2.Fe.O4S |
Molecular Weight | 302.041 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Fe++].NCC(O)=O.NCC(O)=O.[O-]S([O-])(=O)=O
InChI
InChIKey=YJYOLOWXCPIBSY-UHFFFAOYSA-L
InChI=1S/2C2H5NO2.Fe.H2O4S/c2*3-1-2(4)5;;1-5(2,3)4/h2*1,3H2,(H,4,5);;(H2,1,2,3,4)/q;;+2;/p-2
Molecular Formula | H2O4S |
Molecular Weight | 98.078 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C2H4NO2 |
Molecular Weight | 74.0587 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Fe |
Molecular Weight | 55.845 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502
Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Iron(II) gluconate (also known as a ferrous gluconate) is used in the treatment of hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, or the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For the patients who cannot tolerate the usual iron compounds, it is important to have a medication which is effective and which causes minimum disturbance. Ferrous gluconate is such a medicament.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Primary | Ferro Sanol Duodenal Approved UseFerro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia. |
|||
PubMed
Title | Date | PubMed |
---|---|---|
FERROUS IODIDE AND LINOLEIC ACID IN VITAMIN A DEFICIENCY. A REPLY TO CERTAIN CRITICISMS. | 1932 Nov 11 |
|
[Historical notes on the therapy of depression]. | 1986 Nov 22 |
|
Determination of water in ferrous lactate by near infrared reflectance spectroscopy with a fibre-optic probe. | 1997 Oct |
|
A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts. | 2014 |
|
Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle. | 2017 May 1 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/ppa/ferrous-salts.html
Unknown
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:10:52 GMT 2023
by
admin
on
Sat Dec 16 02:10:52 GMT 2023
|
Record UNII |
56PS9HY5XI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
B03AA01
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
||
|
WHO-VATC |
QB03AA01
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
238-784-3
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
DB14501
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
167159
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
105655
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | RxNorm | ||
|
56PS9HY5XI
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
DTXSID20933088
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
CHEMBL3707208
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
SUB26615
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
14729-84-1
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY |